REG - CVS Group plc - CEO retirement

CVSAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260330:nRSd5920Ya&default-theme=true

RNS Number : 5920Y  CVS Group plc  30 March 2026

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

30 March 2026

CVS Group plc ("CVS" or the "Group")

CEO retirement

 

The Board of CVS, the UK listed veterinary group and leading provider of
veterinary services with operations in the UK and Australia, announces that
Richard Fairman has informed the Board of his intention to retire from the
Board and his role as Chief Executive Officer for personal reasons. Under
Richard's leadership, CVS has delivered sustainable growth alongside
successful international expansion into the Australian market, reached the
conclusion of the CMA process and moved to the Main Market of the London Stock
Exchange alongside FTSE 250 index inclusion.

 

Richard will remain in post until a successor is appointed, to ensure an
orderly transition, and he will continue to drive the business forward in the
meantime. The Board will initiate an executive search process to identify a
successor to lead CVS through its next phase of growth.

 

On behalf of the Board, David Wilton, Chair of CVS, said:

 

"Since joining CVS in 2018 as CFO and assuming the role of CEO in 2019,
Richard has led the Group through a period of significant strategic progress
in support of its purpose to provide the best possible care to animals. Under
Richard's leadership, CVS has built a culture centered on clinical excellence,
strengthened its position as veterinary employer of choice and delivered
sustainable growth alongside successful international expansion into the
Australian market. During Richard's tenure, the Group has grown to c.9,000
employees including c.2,500 vets and 3,300 veterinary nurses and patient care
assistants across c.475 practices and EBITDA has nearly tripled. Richard also
guided the business with integrity and clarity through to the conclusion of
the CMA process and, during the same period, oversaw the Group's step-up to
the Main Market of the London Stock Exchange and its subsequent inclusion into
the FTSE 250 index.

 

"On behalf of the Board and everyone at CVS, I would like to take this
opportunity to thank Richard for his commitment over the past eight years and
recognise the significant contribution he has made to the Group. As Chair, I
look forward to continuing to work with him over the coming months and to
ensure an orderly hand over to his successor in due course."

 

Richard Fairman, CEO of CVS said:

 

"It has been a privilege to lead such a talented team of people and I am proud
of the part I have played in helping shape CVS into one of the UK's largest
veterinary groups. Whilst I will be stepping down for my own personal reasons,
I remain firmly committed to supporting the business and ensuring continuity
as the search for a successor begins and an appointment is made.  With
clarity provided by the CMA outcome, a rapidly expanding presence in Australia
and a growing UK business with acquisitions back on the agenda, I believe the
outlook for CVS is positive and the Group is well-positioned to attract a
high-calibre successor."

 

ENDS

 

Contacts

CVS Group plc
 
 
     via Camarco

Richard Fairman, CEO

David Wilton, Chair

 

Camarco (Financial PR)
 
                                          cvsg@camarco.co.uk

Ginny Pulbrook
 
 
+44 (0)7961 315 138

Letaba Rimell

 

About CVS Group plc (www.cvsukltd.co.uk)

CVS is a leading provider of veterinary services, operating in the UK and
Australia and listed on the Main Market of the London Stock Exchange. CVS is
focused on providing high-quality clinical services to its clients and their
animals, with outstanding and dedicated clinical teams and support colleagues
at the core of its strategy.

 

The Group operates c.475 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an Online Retail
Business ("Animed Direct").

 

The Group employs c.9,000 personnel, including c.2,500 veterinary surgeons and
c.3,300 nurses and patient care assistants.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAPPUAUWUPQPGB



            Copyright 2019 Regulatory News Service, all rights reserved